sitagliptin tad 100 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin tad 50 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
sitagliptin tad 25 mg filmom obalené tablety
tad pharma gmbh, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
dabahib 150 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 75 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
dabahib 110 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - dabigatránetexilát - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
paracetamol pxgpharma 500 mg filmom obalené tablety
pxg pharma gmbh, nemecko - paracetamol - 07 - analgetica, antipyretica
clopidogrel tad
tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
sunitinib g.l. pharma 50 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - sunitinib - 44 - cytostatica
sunitinib g.l. pharma 25 mg tvrdé kapsuly
g.l. pharma gmbh, rakúsko - sunitinib - 44 - cytostatica